www.fdanews.com/articles/72889-ranbaxy-gets-tentative-fda-approval
Ranbaxy Gets Tentative FDA Approval
June 1, 2005
Ranbaxy Laboratories has received tentative approval to manufacture and market lamivudine in a 150-mg tablet.
Lamivudine is the generic equivalent of GlaxoSmithKline's (GSK) HIV drug Epivir. Epivir generated roughly $250 million in revenues in the U.S. last year, according to GSK.